Renalytix PLC Stock Ownership - Who owns Renalytix?

Insider buying vs selling

Have Renalytix PLC insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when RNLX insiders and whales buy or sell their stock.

RNLX Shareholders

What type of owners hold Renalytix PLC stock?
Christopher Mills10.34%10,072,500$4.08MInsider
James Renwick McCullough2.82%2,746,386$1.11MInsider
School Of Medicine At Mount Sinai Icahn2.39%2,331,239$944.15kInsider
O. James Sterling1.85%1,805,236$731.12kInsider
Gilder Gagnon Howe Co LLC1.04%1,011,884$409.81kInstitution
Pinnacle Associates Ltd0.81%785,962$318.31kInstitution
Pentwater Capital Management LP0.61%598,440$242.37kInstitution
Fergus Fleming0.58%569,481$230.64kInsider
Tejara Capital Ltd0.41%400,394$162.16kInstitution
Allspring Global Investments Holdings LLC0.35%341,820$138.44kInstitution

1 of 3

RNLX vs Health Information Service Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
UTRS7.94%92.06%Net Buying
STRM26.39%73.61%Net BuyingNet Selling
CCLD13.55%13.56%Net BuyingNet Buying

Renalytix Stock Ownership FAQ

Who owns Renalytix?

Renalytix (NASDAQ: RNLX) is owned by 4.61% institutional shareholders, 18.12% Renalytix insiders, and 77.27% retail investors. Christopher Mills is the largest individual Renalytix shareholder, owning 10.07M shares representing 10.34% of the company. Christopher Mills's Renalytix shares are currently valued at $4.24M.

If you're new to stock investing, here's how to buy Renalytix stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.